A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age
Condition: Measles; Mumps; Rubella; Chickenpox Interventions: Biological: Investigational MMRV(H)NS vaccine; Biological: Investigational MM(H)RVNS vaccine; Biological: Investigational M(L)M(L)R(L)V(L)NS vaccine; Biological: Marketed MMRV_Lot 1 and Lot 2 vaccine Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials
The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine
Conditions: Human Papilloma Virus Infection Type 16; Human Papilloma Virus Infection Type 18; Measles; Rubella; Mumps Interventions: Biological: HPV+MMR（0d），HPV（6m）; Biological: HPV（0d），HPV（6m），MMR（7m）; Biological: MMR（0d），HPV（1m），HPV（7m） Sponsor: Zhejiang Provincial Center for Disease Control and Prevention Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2022 Category: Research Source Type: clinical trials
